Chiron plans Congressional testimony on flu vaccine suspension
642998
EMERYVILLE, Calif. Officials of the Chiron corporation plan to testify before Congress about the manufacturing problems in a British factory preventing the company from releasing its flu vaccine to the public.
717470
The U.S. Congress began  investigating on Wednesday whether the U.S. Food and Drug  Administration overlooked problems at a British plant that led  to the withdrawal of half the country's flu vaccine supply.
19709
Last week, the Chiron Corporation, which manufactures close to half of America&#39;s influenza vaccine supply announced a delay in shipping its Fluvirin influenza virus vaccine, due to the possibility of contaminated doses.
239033
The S.E.C. has launched an informal inquiry into how Chiron handled the disclosure of vaccine-manufacturing problems that caused the nation's flu shot crisis.
244248
The Food and Drug Administration is unlikely to clear influenza vaccine made by Chiron Corp. as safe for Americans to use this flu season, Dr. Lester M. Crawford, the agency's acting commissioner, said Friday. It was unclear whether the lack of vaccine might lead to more flu deaths this year.
444060
U.S. regulators want Chiron Corp. to  tell them how they are going to fix contamination problems at a  British vaccine plant that wiped out half the U.S. flu shot  supply this year, the company said on Friday.
702526
U.S. regulators were trying to decide whether to allow the release of 48 million doses of Chiron Corp.'s flu vaccine when British authorities stepped in to block the company from shipping the vaccine, FDA officials said Friday.
726552
This year&#39;s US flu vaccine will be safe and will be distributed on time, Chiron Corp. President and Chief Executive Officer Howard Pien pledged on Tuesday.
287660
In a hearing on the national flu vaccine shortage, the House Energy and Commerce Subcommittee on Health on Thursday requested that FDA, HHS and flu vaccine manufacturer Chiron by Dec. 1 produce documents detailing
646530
U.S. regulators probably would have  made the same decision as British authorities to shut down  Chiron Corp.'s flu vaccine plant if they had the same  information about manufacturing problems, the acting head of  the Food and Drug Administration said on Friday.
656690
The U.S. Congress began investigating on Wednesday whether the U.S. Food and Drug Administration overlooked problems at a British plant that led to the withdrawal of half the country's flu vaccine supply.
256905
WASHINGTON Nov 15, 2004 - Chiron Corp. has asked British regulators to inspect its facility producing an experimental bird flu vaccine to make sure it doesn&#39;t run into the same contamination problems that
384479
Chiron Corp. is working with British regulators who suspended its license to sell a flu vaccine and is hoping authorities will lift the suspension in time for the 2005/2006 flu season, the company said on Friday.
126844
The decision by British authorities to suspend the license of a major influenza vaccine manufacturer just before the vaccine was to be shipped shows a need for better communication, acting FDA chief Dr. Lester Crawford said on Monday.
524016
Congress yesterday began investigating whether the US Food and Drug Administration overlooked problems at a British plant that led to the withdrawal of half the US flu vaccine supply.
140440
Description: Congress will hold hearings to determine how the nation wound up facing a shortage of influenza vaccine. About 40 million doses -- roughly half the anticipated US supply -- were impounded in Great
45398
Chiron Corp. (CHIR.O: Quote, Profile, Research) , barred from shipping its flu vaccine after it was found to be contaminated, on Wednesday posted a quarterly